BioMarin Pharmaceutical
BMRN
#1907
Rank
A$15.44 B
Marketcap
A$80.39
Share price
-0.78%
Change (1 day)
-21.62%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$2.34 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's total liabilities are A$2.34 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioMarin Pharmaceutical - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$2.13 B-22.87%
2023-12-31A$2.77 B6.54%
2022-12-31A$2.60 B8.55%
2021-12-31A$2.39 B5.88%
2020-12-31A$2.26 B1.18%
2019-12-31A$2.23 B8.1%
2018-12-31A$2.07 B-11.37%
2017-12-31A$2.33 B33.97%
2016-12-31A$1.74 B-4.35%
2015-12-31A$1.82 B57.52%
2014-12-31A$1.15 B14.36%
2013-12-31A$1.01 B90.39%
2012-12-31A$0.53 B2.36%
2011-12-31A$0.51 B-3.24%
2010-12-31A$0.53 B-18.94%
2009-12-31A$0.66 B-25.83%
2008-12-31A$0.89 B24.41%
2007-12-31A$0.71 B63.71%
2006-12-31A$0.43 B17.62%
2005-12-31A$0.37 B-4.14%
2004-12-31A$0.38 B108.73%
2003-12-31A$0.18 B769.45%
2002-12-31A$21.42 M-10.82%
2001-12-31A$24.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ultragenyx Pharmaceutical
RARE
A$1.76 B-24.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$0.12 B-94.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$1.22 B-47.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$99.40 B 4,137.50%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
A$0.96 B-59.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$0.19 B-91.57%๐Ÿ‡บ๐Ÿ‡ธ USA